Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Email this article to a friend

Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer

Felicita Baratelli* email, Hiroko Takedatsu* email, Saswati Hazra email, Katherine Peebles email, Jie Luo email, Pam S Kurimoto email, Gang Zeng email, Raj K Batra email, Sherven Sharma email, Steven M Dubinett email and Jay M Lee email

Journal of Translational Medicine 2008, 6:38doi:10.1186/1479-5876-6-38

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.